JPRN-UMIN000015120尚未招募未知
Pilot study of efficacy and safety of Rikkunshito for adverse events (nausea, emesis and anorexia) caused by chemotherapy (GD therapy) for high-grade soft tissue sarcomas. - Pilot study of Rikkunshito for adverse events caused by chemotherapy (GD therapy).
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with double cancer 2. Patients who took Kampo within 4 weeks 3. Patients with any other severe diseases 4. Pregnat patients 5. Other exclusionary comobidity
研究者
相似试验
尚未招募
不适用
Pilot study of efficacy and safety of Rikkunshito for adverse events (nausea, emesis and anorexia) caused by chemotherapy (modified MAID therapy) for high grade bone and soft tissue sarcomas.High-grade bone and soft tissue sarcomasJPRN-UMIN000015113Tokyo Metropolitan Komagome Hospital10
已完成
不适用
The study for the efficacy of rikkunshito on anorexia in the patients who underwent laparoscopy assisted gastrectomy and open gastrectomyGastric cancer patient who underwent laparoscopy assisted gastrectomy or open gastrectomyJPRN-UMIN000008564Department of Gastroenterological and General Surgery St.Marianna University School of Medicine Hospital60
已完成
不适用
The exploratory study for the efficacy of rikkunshito on anorexia in the patients with TS-1 treatmentGastric cancerJPRN-UMIN000003014Saitama Medical Center, Saitama Medical University20
已完成
不适用
A pilot study to evaluate efficacy and safety of resveratrol for muscular dystrophy.Duchenne muscular dystrophy, Becker muscular dystrophy, Fukuyama congenital muscular dystrophyJPRN-UMIN000014836Sapporo Medical University10
招募中
2 期
Randomized phase II study of rikkunshito on chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy for lung cancer (HOT1403)ung CancerJPRN-UMIN000014240Hokkaido Lung Cancer Clinical Study Group62